Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade.

FDA approves smaller levonorgestrel intrauterine system — a 'mini Mirena'